as of 12-05-2025 3:44pm EST
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes and corn-based products in North and South America.
| Founded: | 1818 | Country: | United States |
| Employees: | N/A | City: | GENEVA |
| Market Cap: | 18.1B | IPO Year: | N/A |
| Target Price: | $107.83 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 8.69 | EPS Growth: | 9.16 |
| 52 Week Low/High: | $67.40 - $99.55 | Next Earning Date: | 11-05-2025 |
| Revenue: | $60,109,000,000 | Revenue Growth: | 10.29% |
| Revenue Growth (this year): | 28.45% | Revenue Growth (next year): | 26.02% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Executive VP, Global Markets
Avg Cost/Share
$94.38
Shares
25,300
Total Value
$2,387,644.19
Owned After
124,536.808
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Dimopoulos Christos | BG | Executive VP, Global Markets | Nov 21, 2025 | Sell | $94.38 | 25,300 | $2,387,644.19 | 124,536.808 |
See how BG stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "BG Bunge Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.